Kaposi's Sarcoma Clinical Trials

A listing of Kaposi's Sarcoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
A Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma

This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the

  • 0 views
  • 27 Oct, 2022
  • 2 locations
Randomized Trial to Evaluate Mirasol Whole Blood Pathogen Reduction Technology System to Reduce Malaria and Emerging Transfusion Transmitted Infections (MERIT)

This is a prospective, randomized, double-blind, controlled study to determine the effectiveness of Mirasol-treated fresh whole blood (FWB) versus Standard-issue FWB for preventing transmission of transfusion-transmitted infections (TTIs). The incidence of pre-defined viral, bacterial, or parasitic TTIs in previously negative participants will be assessed by changes in laboratory findings at …

  • 3 views
  • 27 Oct, 2022
  • 1 location
A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

if sEphB4-HSA will decrease the number or size of Kaposi sarcoma lesions in people.

HIV Infection
doxorubicin
elisa
western blot
carcinoma
  • 2 views
  • 25 Oct, 2022
  • 3 locations
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

This phase I trial studies the best dose and effects of NT-I7 in treating Kaposi sarcoma in patients with or without HIV. NT-I7 works by using a patient's immune system to fight cancer. It is

antiviral drugs
hepatitis
protease
AIDS
HIV Vaccine
  • 0 views
  • 04 Oct, 2022
  • 3 locations
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

This phase II clinical trial studies the side effects of pomalidomide and how well it works in treating patients with Kaposi sarcoma and human immunodeficiency virus (HIV) infection. Biological

  • 0 views
  • 04 Oct, 2022
  • 2 locations
Phase I/II of NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Background Kaposi sarcoma (KS) tumors grow on the skin, lymph nodes, lungs, bone, and gastrointestinal tract. KS often affects people with immune deficiencies

doxorubicin
direct bilirubin
systemic chemotherapy
monoclonal antibodies
protease
  • 12 views
  • 22 Oct, 2022
  • 1 location
A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Background Kaposi Sarcoma (KS) is common in people with human immunodeficiency virus (HIV) but can also occur in people who do not have HIV. KS tumors usually

protease
AIDS
cancer
atazanavir
breast cancer
  • 0 views
  • 25 Oct, 2022
  • 1 location
A Phase 1 Trial of Pomalidomide in Combination With Liposomal Doxorubicin in Patients With Advanced or Refractory Kaposi Sarcoma

Background Kaposi sarcoma (KS) is a cancer most often seen in people with HIV. It causes lesions. These are usually on the skin but sometimes in the lymph nodes

aspirin
antiretroviral agents
antiretroviral therapy
cancer chemotherapy
systemic therapy
  • 11 views
  • 25 Oct, 2022
  • 1 location
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) Incorporating Pilot Evaluation of KSHV Targeted Therapies

Background KSHV inflammatory cytokine syndrome (KICS) is a newly recognized disease caused by Kaposi sarcoma-associated herpesvirus (KSHV). This virus can cause

doxorubicin
fever
herpes
lymphoma
edema
  • 81 views
  • 24 Oct, 2022
  • 1 location
A Phase I Study of Pomalidomide and Nivolumab in Patients With Virus-Associated Malignancies With or Without HIV

viruses. Eligibility Adults ages 18 or older who have cancers caused by Epstein Barr virus (EBV), human herpes virus 8/Kaposi sarcoma herpesvirus (HHV8/KSHV), human

immunohistochemistry
aspirin
leiomyosarcoma
lymphoma
antiretroviral therapy
  • 0 views
  • 21 Oct, 2022
  • 1 location